ClinicalTrials.gg
Not yet recruitingNCT07137520activityUpdated Aug 22, 2025

The Impact of Various Exercise Intensities on Energy Expenditure Metabolism

An observational study in Physical Activity, sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Motor Activity with a site in China — 41 open to participants now, 49 under way, 1 of them phase 3. Motor Activity · China.

Planned enrollment
13th of 19
100 · median 221
Started
2025
with 12 others
Observational
19 of 132
9 open now
Primary completion
2026-12
later than 28 of 48 live
Registered
93rd of 132
by date
Lead sponsor
6 of 132
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Among the 132 studies in Motor Activity with a site in China, this one is the 13th largest by planned enrollment of the 19 observational ones that give a count, is one of 13 that started in 2025, is one of 19 observational ones, reaches primary completion later than 28 of the 48 other live ones, and was the 93rd registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

41 of the 132 studies in Motor Activity with a site in China are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Motor Activity with a site in China, or all of them as a file.
02

Study summary

The goal of this observational study is to learn about the effects of physical activity in adult on metabolic response. The main question it aims to answer is:

  • if physical activity is unlimited to increase the total energy expenditure (TEE)?

Participants will engage in the following measurements:

  • Record their daily physical activity by GT3X.
  • Measure TEE by doubly-labeled water (DLW) method
  • Measure basal energy expenditure(BEE) and thermic effect of food(TEF) by respiratory chamber
Read the detailed description

The purpose of this study is to explore the effect of various physical activities on metabolic and behavior response. Energy expenditure, body composition, and metabolism will be measured by the following measurements:

  • TEE:

TEE will be measured using the DLW method. Urine samples from all participants in the DLW subset will be stored at -20℃ and shipped on dry ice for analysis in the laboratory of Prof. John Speakman at the Shenzhen Institutes of Advanced Technology, Chinese academy of sciences. Isotopes will be measured in benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation. TEE will then be calculated using mean CO2 production.

  • REE and TEF:

REE and TEF will be measured by indirect calorimetry while participants are resting supine in a respiratory chamber with thermoneutral conditions. Oxygen consumption and CO2 production will be measured to calculate energy expenditure. REE will be consistently measured throughout sleeping at night and in the morning after overnight fasting, and TEF will be measured after breakfast.

  • Physical activity:

Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 14 days. The monitor should not be worn while bathing or swimming. The first day is discarded along with any day with less than 12 hours of wear. For a valid measure the goal is to get 2 weekday and 2 weekend days.

  • VO2max test:

Participants need to warm up with simple stretching or light aerobic exercise before the test. The test will be conducted on a treadmill. A comfortable running speed acceptable to the participants will be set. The treadmill's incline will be increased by 10% every two minutes until the individual reaches their physical limit and can no longer continue. During this test, a respiratory mask and gas analyzer will be used to measure the concentration of oxygen (O2) and carbon dioxide (CO2) in the breath to calculate VO2max.

  • Food intake

Photographic and food weighing methods to record food intake for two random days throughout the period of DLW measurement.

  • Blood glucose

Fasting and post-prandial glucose will be recorded by a continuous glucose monitoring system.

  • Body composition:

Fat mass will be measured by Magnetic Resonance Imaging (MRI, Shanghai united imaging, uMR 790 ).

Bioimpedance Analysis will measure fat-free mass (Tanita, MC-980). Bone mass will be measured by Dual Energy X-ray Absorptiometry (DXA, Horizon Wi, HOLOGIC).

  • Body weight:

At visit 1, fasting body weight will be measured using a calibrated seca at the beginning of the visit. Fasting weight will be measured at visit 2 and, if applicable.

  • Height:

Height (to +0.1 cm) will be measured by seca 217 stable without wearing shoes.

  • Waist circumference:

Hip and waist circumference (to +0.3 cm) will be measured using a whole body laser scanner.

  • Blood pressure:

Systolic and diastolic blood pressure will be measured using an Omron digital sphygmomanometer.

03

Conditions studied

  • Physical Activity

Browse trials for

Keywords

  • Metabolic response
  • Energy expenditure
  • Physical fitness
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Residents of Shenzhen, Guangzhou, China

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 18.5 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Individuals who have undergone major surgery in the past 6 months (excluding tooth extraction);
  • Individuals with severe metabolic and cardiovascular diseases such as diabetes, hypoglycemia, and hypertension;
  • Individuals with exercise-related injuries, including joint diseases and fractures;
  • Individuals diagnosed with infectious diseases such as , tuberculosis, malaria, etc.;
  • Individuals with mental and neurological disorders including anorexia nervosa;
  • Individuals who have attempted weight loss or gain through various methods in the past three months;
  • Individuals in preconception, pregnancy, and lactation periods;
  • Individuals with autism and those with metal implants in their bodies.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Sedentary group

    Godin scale score ≥ 24

    Other: Observation without intervention

  • Moderately active group

    14≥ Godin scale score ≥ 23

    Other: Observation without intervention

  • Active group

    Godin scale score \<14

    Other: Observation without intervention

Interventions

  • OtherObservation without intervention

    Observation without intervention

06

What researchers measure

Primary outcomes

  1. Differences in total energy expenditure (TEE) measured by the doubly labeled water (DLW) method across experimental groups

    \- The change in TEE will be evaluated using the DLW. Urine samples from all participants in the DLW subset will be stored at -20℃ and shipped on dry ice for analysis in the laboratory of Dr. John Speakman at the University of Aberdeen, or the Shenzhen Institutes of Advanced Technology, Chinese academy of sciences. Isotopes will be measured in benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation (Speakman et al 2021: Cell reports medicine). TEE will then be calculated using mean CO2 production using the Weir equation.

    Time frame: 14days

  2. Differences in non-exercise physical activity across experimental groups

    \- Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 14 days.

    Time frame: 14days

  3. Differences in resting energy expenditure (REE) measured by respiratory chamber across experimental groups

    \- REE will be evaluated by respiratory chamber.

    Time frame: 1 day

  4. Differences in thermic effect of food (TEF) measured by respiratory chamber across experimental groups

    \- TEF will be evaluated by respiratory chamber.

    Time frame: 1 day

  5. Differences in exercise energy expenditure (EEE) measured by COSMED across experimental groups

    \- EEE will be evaluated using an indirect calorimetry COSMED.

    Time frame: 1 hour

  6. Differences in food intake across experimental groups

    Photographic and food weighing methods to record food intake for two random days throughout the period of DLW measurement

    Time frame: 2 days

Secondary outcomes

  1. Differences in sedentary time measured by GT3X accelerometer across experimental groups

    \- Sedentary time will be represented from the GT3X accelerometer.

    Time frame: 14 days

  2. Differences in glucose across experimental groups

    Fasting and post-prandial glucose will be recorded by a continuous glucose monitoring system.

    Time frame: 7 days

  3. Differences in fat mass across experimental groups

    Fat mass will be measured by Magnetic Resonance Imaging (Shanghai united imaging, uMR 790 ).

    Time frame: 10 minutes

  4. Differences in fat-free mass across experimental groups

    Fat-free mass will be measured by Bioimpedance Analysis (Tanita, MC-980).

    Time frame: 2 minutes

  5. Differences in bone mass intensity across experimental groups

    Bone mass intensity will be measured by DXA( Horizon Wi, HOLOGIC)

    Time frame: 7 minutes

  6. Differences in circulating hormones across experimental groups

    The nurse will collect the fasting blood sample. Metabolomics will analyze circulating hormones and metabolites.

    Time frame: 1 minutes for collection, 7 days for analysis.

  7. Differences in intestinal microbiota across experimental groups

    Feces will be collected for gut microbiome analysis of intestinal microbiota.

    Time frame: 5 minutes for collection, 7 days for analysis.

07

Study locations

1 site
08

References and documents

Publications

  • Speakman JR, Yamada Y, Sagayama H, Berman ESF, Ainslie PN, Andersen LF, Anderson LJ, Arab L, Baddou I, Bedu-Addo K, Blaak EE, Blanc S, Bonomi AG, Bouten CVC, Bovet P, Buchowski MS, Butte NF, Camps SGJA, Close GL, Cooper JA, Creasy SA, Das SK, Cooper R, Dugas LR, Ebbeling CB, Ekelund U, Entringer S, Forrester T, Fudge BW, Goris AH, Gurven M, Hambly C, El Hamdouchi A, Hoos MB, Hu S, Joonas N, Joosen AM, Katzmarzyk P, Kempen KP, Kimura M, Kraus WE, Kushner RF, Lambert EV, Leonard WR, Lessan N, Ludwig DS, Martin CK, Medin AC, Meijer EP, Morehen JC, Morton JP, Neuhouser ML, Nicklas TA, Ojiambo RM, Pietilainen KH, Pitsiladis YP, Plange-Rhule J, Plasqui G, Prentice RL, Rabinovich RA, Racette SB, Raichlen DA, Ravussin E, Reynolds RM, Roberts SB, Schuit AJ, Sjodin AM, Stice E, Urlacher SS, Valenti G, Van Etten LM, Van Mil EA, Wells JCK, Wilson G, Wood BM, Yanovski J, Yoshida T, Zhang X, Murphy-Alford AJ, Loechl CU, Melanson EL, Luke AH, Pontzer H, Rood J, Schoeller DA, Westerterp KR, Wong WW; IAEA DLW database group. A standard calculation methodology for human doubly labeled water studies. Cell Rep Med. 2021 Feb 16;2(2):100203. doi: 10.1016/j.xcrm.2021.100203. eCollection 2021 Feb 16. PubMed 33665639 ↗
  • Pontzer H, Durazo-Arvizu R, Dugas LR, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Cooper RS, Schoeller DA, Luke A. Constrained Total Energy Expenditure and Metabolic Adaptation to Physical Activity in Adult Humans. Curr Biol. 2016 Feb 8;26(3):410-7. doi: 10.1016/j.cub.2015.12.046. Epub 2016 Jan 28. PubMed 26832439 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Dec 2026, 15 months later.

Of 492 non-industry observational studies under Motor Activity, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's planned 15 months is below that.

Counting every sponsor, half of 502 studies reached it within 22 months; a quarter within 8 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2025
First posted
Aug 22, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2027
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07137520
Lead sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Responsible party
John R. Speakman (Professor, Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences) — Principal investigator
First posted
Aug 22, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Aug 22, 2025

Study contacts

John R Speakman, PhD
Contact
j.speakman@abdn.ac.uk
+8615810868669
Xinyi BI, PhD
Contact
xy.bi@siat.ac.cn
+8614774821721
John R Speakman, PhD
principal investigator · Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion